On Tuesday, Elevance Health Inc (NYSE: ELV) opened lower -0.42% from the last session, before settling in for the closing price of $542.72. Price fluctuations for ELV have ranged from $412.00 to $550.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 13.24%. Company’s average yearly earnings per share was noted 12.48% at the time writing. With a float of $231.34 million, this company’s outstanding shares have now reached $233.07 million.
Let’s determine the extent of company efficiency that accounts for 104900 employees.
Elevance Health Inc (ELV) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Elevance Health Inc is 0.46%, while institutional ownership is 90.84%. The most recent insider transaction that took place on Apr 24 ’24, was worth 3,300,590. In this transaction EVP & President,Gov Health Ben of this company sold 6,199 shares at a rate of $532.44, taking the stock ownership to the 27,304 shares. Before that another transaction happened on Apr 23 ’24, when Company’s EVP & President,Gov Health Ben sold 14,111 for $533.74, making the entire transaction worth $7,531,565. This insider now owns 31,460 shares in total.
Elevance Health Inc (ELV) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 12.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.10% during the next five years compared to 12.18% growth over the previous five years of trading.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Check out the current performance indicators for Elevance Health Inc (ELV). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.73. Likewise, its price to free cash flow for the trailing twelve months is 54.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 26.46, a number that is poised to hit 10.02 in the next quarter and is forecasted to reach 41.64 in one year’s time.
Technical Analysis of Elevance Health Inc (ELV)
Looking closely at Elevance Health Inc (NYSE: ELV), its last 5-days average volume was 1.81 million, which is a jump from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 83.44%. Additionally, its Average True Range was 11.25.
During the past 100 days, Elevance Health Inc’s (ELV) raw stochastic average was set at 90.22%, which indicates a significant increase from 83.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.46% in the past 14 days, which was higher than the 18.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $524.99, while its 200-day Moving Average is $485.72. However, in the short run, Elevance Health Inc’s stock first resistance to watch stands at $543.64. Second resistance stands at $546.85. The third major resistance level sits at $549.90. If the price goes on to break the first support level at $537.38, it is likely to go to the next support level at $534.33. Now, if the price goes above the second support level, the third support stands at $531.12.
Elevance Health Inc (NYSE: ELV) Key Stats
There are currently 232,418K shares outstanding in the company with a market cap of 125.61 billion. Presently, the company’s annual sales total 171,340 M according to its annual income of 5,987 M. Last quarter, the company’s sales amounted to 42,577 M and its income totaled 2,246 M.
